On Demand Catch the Best of IMS 2024Whenever You Want the perfect way to access the congress highlights that matter most to you Are you unable to attend the IMS 2024 Congress in Melbourne? Don’t miss the opportunity to watch the congress sessions On Demand!Starting from November 11th, IMS 2024 On Demand will give you access to all the 94 sessions from the congress. We offer credits in convenient packages 5 CREDITS 50 AUD 2.5 hours of video content 10 CREDITS 100 AUD 5 hours of video content 20 CREDITS 180 AUD 10 hours of video content Not sure how many credits to purchase? Check the program to estimate how many credits you might need. Don’t worry—you can always add more credits at any time! Featured Sessions Opening Ceremony Welcome to Congress Close Nick Panay Rodney Baber Plenary Lecture Not Just Sex: Other Roles for Testosterone in Women 1 Credit 30:00 Close Susan Davis Not Just Sex: Other roles for testosterone in women Symposium Postmenopausal Pelvic Floor Health 3 Credits 1:30:00 Close Lynsey Hayward Midlife Bladder Problems: Initial assessment and managementPhilip Toozs-Hobson Stress Urinary Incontinence: What do we do now?Tommaso Simoncini What To Do with A Prolapse: Non-surgical and surgical options Symposium by CAMS Society Understanding Genitourinary Syndrome of Menopause (GSM): Impacts, pathophysiology and emerging therapies 3 Credits 1:30:00 Close Céline Bouchard Estrogen and Androgen role in vaginal health and GSM: what do we know?Shafeena Premji GSM: Vital discussions for menopausal women and its impact on quality of life Symposium by CAMS Society What’s New and Important in Menopause Care 3 Credits 1:30:00 Close Kyu Ri Hwang Obesity Treatment for Postmenopausal WomenSeokkyo Seo Hormone Replacement Therapy and Breast Cancer Incidence in Korean Women Jae Yen Song Menopause and Mental Health Eun-Hee Yoo DiscussantSang Ho Yoon DiscussantSungwook Chun DiscussantSeung-Yup Ku DiscussantSa Ra Lee DiscussantHoon Kim Discussant Hyuntae Park DiscussantJoo Jongkil DiscussantDong-Yun Lee DiscussantSihyun Cho Discussant Sponsored Lunch Symposium The Importance of Individualizing MHT and Its Impact on Cardiovascular Health in Postmenopausal Women 3 Credits 1:30:00 Close Amanda Vincent Welcome and IntroductionAmanda Vincent Individualized MHT and Cardiovascular Health: A clinical practice prospectiveSantiago Palacios Individualized MHT: Introducing a new Menopause Treatment Tool (MTT)Sonia Davison Menopause and Cardiovascular HealthJohn Stevenson Major Cardiovascular Events Incidence (MACE) of Oral Combined MHT Estradiol/Micronized Progesteron: US data from Real World Evidence Discussion and Q&A Plenary Lecture Heart Matters: The Unique Landscape of CV Health in Women 1 Credit 30:00 Close Gemma Figtree Heart Matters: The unique landscape of CV health in women Symposium Menopausal Complexities 2 Credits 1:00:00 Close Haitham Hamoda NICE, Menopause and MHT: A clinician’s perspectiveJanice Rymer Medical Management of Endometriosis (New drugs, use of MHT after surgical menopause) Sponsored Symposium VA/GSM and Lichen Sclerosus: Clinical Best Practice and Evidence for new therapies 2 Credits 1:00:00 Close Andrew Goldstein Clinical Best Practice for Lichen Sclerosus: Managing disease, symptoms and patient QOLMarc Winter Navigating GSM Therapy Landscapes in the USA: A deep dive into StrataMGT and current studiesPhilip Hall Patient-Centric Outcomes in Lichen Sclerosus (LS) and GSM: Insights from Australian clinical trialEduardo Serrano Clinical Trial Insights on Emerging Therapies (StrataMGT): Facilitating clinical engagement and presenting preliminary data Symposium Menopause in Latin America 2 Credits 1:00:00 Close Maria Celeste Wender Menopause in BrazilDavid Vasquez Awad Menopause in ColombiaSonia Cerdas Menopause in Costa Rica Opening Ceremony Welcome to Country 2 Credits 15:00 Close Amanda Vincent Susan Davis Opening Ceremony Opening of the congress by the Assistant Minister for Health, Aged Care and Indigenous Affairs 2 Credits 25:00 Close Hon. Ged Kearney Opening of the Congress Awards Henry Burger Award 2 Credits 25:00 Close Panagiotis Anagnostis Plenary Lecture Pieter Van Keep Lecture - Premature Ovarian Insufficiency 1 Credit 30:00 Close Nick Panay Premature Ovarian Insufficiency Meet the Expert MHT for primary prevention 2 Credits 1:00:00 Close John Stevenson MHT for Primary Prevention Meet the Expert Optimizing Cardiometabolic Health in midlife women 2 Credits 1:00:00 Close Peter Chedraui Optimizing Cardiometabolic Health in Midlife Women Meet the Expert PCOS and the menopause transition 2 Credits 1:00:00 Close Duru Shah PCOS and the Menopause Transition Meet the Expert Bleeding through Menopause Transition and Beyond: Evaluation and Mx. 2 Credits 1:00:00 Close Steven R. Goldstein Bleeding through Menopause Transition and Beyond: Evaluation and Mx. Plenary Lecture Medical Management of Obesity: Unlocking the Potential 1 Credit 30:00 Close Priya Sumithran Medical Management of Obesity: Unlocking the potential Plenary Lecture Long Term Strategies for Osteoporosis Care 1 Credit 30:00 Close Eugene McCloskey Long Term Strategies for Osteoporosis Care Symposium Mental Health 3 Credits 1:30:00 Close Pauline Maki Perimenopausal Cognitive ChangesClaudio Soares Menopause and Depression: How to manage?Herman Depypere MHT and Dementia: Is there a link? Symposium Premature Ovarian Insufficiency 3 Credits 1:30:00 Close A Patient’s PerspectiveElena Tucker POI GeneticsRichard Anderson New POI Guidelines: Epidemiology, causes, diagnosis, fertility, pregnancyAmanda Vincent New POI Guidelines: Long term implications Sponsored Symposium The Heart, the Bones and the Vagina: Looking beyond VMS for the management of menopausal symptoms and long-term care with MHT 2 Credits 1:30:00 Close Tommaso Simoncini The Heart: Cardiovascular impact Jean Yves Reginster The Bones: Osteoporosis preventionAngelica Lindén Hirschberg The Vagina: Addressing genito-urinary syndrome of menopause Symposium by CAMS Society The Strategies of Menopause Management and Menopause Hormone Therapy Amongst Chinese Women 3 Credits 1:30:00 Close Yan Wang Implementation and Progress of Drug Research for the Treatment of Menopausal Symptoms in ChinaDanhua Pu Progress of the Etiology in Premature Ovarian InsufficiencyQi Yu The Updated Chinese Guideline of Menopause Management and Menopausal Hormone Therapy Rong Chen New Perspectives on Menopause Management, Reflections from the Lancet Menopause Series 2024 Symposium New and Revisited Therapies 3 Credits 1:30:00 Close Joann Pinkerton SERMS: When to use?Marla Shapiro Non-Hormonal Treatments for MenopauseChoon Moy Ho Menopause And Complementary Therapies: What the science says? Symposium by CAMS Society Menopause experience in the South Asian Women 3 Credits 1:30:00 Close Syeda Batool Mazhar Menopause: A boon or bane for the women of South AsiaManinder Ahuja Cardiometabolic Syndrome in the Midlife and Beyond in Indian WomenSk Zinnat Ara Nasreen Ending Sorrows of GSMKirubamani Hephzibah Setting up a Menopause ClinicRubina Hussain PanelistBrig Surraya Rahman PanelistSumbul Sohail Panelist Debate Should estrogen always be delivered transdermally? 2 Credits 1:00:00 Close Sonia Davison AffirmativeSteven R. Goldstein Opposed Panel Discussion Mental Health Symptoms Management in Menopause 2 Credits 1:00:00 Close Jayashri Kulkarni Panel discussionCaroline Gurvich Panel DiscussionElina Safro Panel Discussion Symposium by CAMS Society Mental Health and Menopause 3 Credits 1:00:00 Close Mala Banik Mental Health and MenopauseLatifa Shamsuddin DiscussantRowshan Ara Begum DiscussantLaila Arjumand Banu DiscussantSameena Chowdhury DiscussantKohinoor Begum DiscussantBrig Suraiya Rahman DiscussantSalma Rouf Discussant Sponsored Lunch Symposium Charting the Course for VEOZA™ ▼(fezolinetant): From clinical discovery to practical use 3 Credits 1:30:00 Close Susan Davis Welcome and IntroductionRossella Nappi Riding the Waves: The challenges of VMS associated with menopauseMarla Shapiro A New Direction: Advances in the management of VMS associated with menopauseSteven R. Goldstein Guiding the Way: Expert insights on the clinical implementation of VEOZASusan Davis Meeting Close Symposium Cancer 3 Credits 1:30:00 Close Howard Carp Realising the Promise of Cancer Predisposition GenesAnna Fenton Menopause After Cancer: Managing the whole womanLudwig Kiesel Advances in Management of Endometrial Cancer Symposium Vulvovaginal Atrophy/Genitourinary Syndrome of Menopause 3 Credits 1:30:00 Close Tim Hillard Genitourinary Changes with AgeSarah Lensen What Should We Assess?Nevine Te West The Impact of The Lower Genital Tract Microbiome Sponsored Symposium Looking Beyond VMS: Sleep disturbances in the menopause 3 Credits 1:30:00 Close Claudio Soares Welcome and IntroductionPaula Briggs What Can We Learn from Real-World Data on Sleep Disturbances During Menopause?Susan Davis Why Does Sleep Matter?Pauline Maki Sleep and Menopause: What are the causes and effects?Claudio Soares Panel Discussion and Q&AClaudio Soares Summary and CloseSusan Davis “Doctor, I’m Not Sleeping” – What’s Next? Symposium by CAMS Society LATIN AMERICAN FEDERATION OF CLIMACTERIC AND MENOPAUSAL SOCIETIES (FLASCYM) 3 Credits 1:30:00 Close David Vasquez Awad Contraception in Menopausal TransitionSonia Cerdas Cardiometabolic Changes During the Menopausal TransitionPablo Carpintero Management of Obesity During the Perimenopause: The key to healthy aging Symposium by CAMS Society Menopause in Asia-Pacific: Cultural perspectives, guidelines, mobility and sleep 2 Credits 1:30:00 Close Qi Yu The Menopausal Symptoms: What are the differences between the West and East?Stella Sugianto Asia-Pacific Menopause Federation (APMF) Consensus Statement on the Management of Menopause 2023Sk Zinnat Ara Nasreen Enjoying Mobility and Independence after Menopause Masakazu Terauchi Sleep Problems in Middle-Aged Women and Its ManagementSeng Bin Ang Asia-Pacific Menopause Federation (APMF) Consensus Statement on the Management of Menopause 2023 Symposium Menopause in Under-Served Populations 2 Credits 1:00:00 Close Xiangyan Ruan Managing the World’s Biggest Menopause ClinicNicole Jaff Menopause in Low and Middle Income CountriesPremitha Damodaran Menopause in a Multi-Ethnic Population: Challenges with attitudes and cultures Debate Should MHT be first line for treating perimenopausal depression? 2 Credits 1:00:00 Close Pauline Maki OpposedJayashri Kulkarni Affirmative Supported Symposium The Balancing Act: Vaginal health and endometrial safety 2 Credits 1:00:00 Close Rossella Nappi Attitudes and Approaches to the GSM James Simon Are Low Dose Vaginal Oestrogens Safe for the Endometrium? Symposium by CAMS Society SITUATION OF MENOPAUSE CLINICS 2 Credits 1:00:00 Close Victor Manuel Vargas Hernandez Situation of Menopause in MexicoAndrea Genazzani Menopause Clinics in EuropeGuillermo Federico Ortiz Luna Menopause Clinics in Latin America Menopause olympics Menopause Olympics - Greenblatt Awards 2 Credits 1:00:00 Close Tim Hillard Nicole Jaff Meet the Expert Hot Flushes, Menopause or Something More Sinister? 2 Credits 1:00:00 Close Christina Jang Hot Flushes, Menopause or Something More Sinister? Meet the Expert Practical management of POI 2 Credits 1:00:00 Close Wendy Wolfman Practical Management of POI Meet the Expert How to get your paper published 2 Credits 1:00:00 Close Tim Hillard How to Get your Paper PublishedJames Pickar How to Get your Paper Published Meet the Expert MHT and breast cancer: a close look at the evidence and strategies for safe practice 2 Credits 1:00:00 Close Robert Langer MHT and Breast Cancer: A close look at the evidence and strategies for safe practice Plenary Lecture Understanding the Perimenopause Journey 1 Credit 30:00 Close Nanette Santoro Understanding the Perimenopause Journey Plenary Lecture Enhancing Quality of Life: Addressing Vulvovaginal Atrophy 1 Credit 30:00 Close Angelica Lindén Hirschberg Enhancing Quality of Life: Addressing vulvovaginal atrophy Sponsored Symposium Sexual Health and Testosterone for Women: Fact, fiction, the future 3 Credits 1:30:00 Close James Simon Sexual Health and Testosterone for Women: Fact, fiction, the futureSharon Parish Sexual Health and Testosterone for Women: Fact, fiction, the future Q&A Symposium Contemporary Issues in Menopause 3 Credits 1:30:00 Close Nick Panay Evidence Based, Modern Management of PMS/PMDDSeng Bin Ang Artificial Intelligence (AI) And Midlife Women’s HealthcareZachary Nash Menopause priority Setting Partnership (maps): The top ten Symposium by CAMS Society MENOPAUSE: A GOLDEN OPPORTUNITY FOR HEALTHY AGEING 3 Credits 1:30:00 Close Pablo Carpintero Healthy Aging: Challenges for the next decadesClaudia Cristina Rey Understaining Brain Fog during PerimenopauseAnalia Cecilia Pesado Vaginal Health: Impact in women's quality of lifeRita Caro Why do we Need to Talk about Obesity and Cardiovascular and Oncologic Risk in Menopause? Symposium by CAMS Society Contemporary practices for midlife management: Indian perspective 3 Credits 1:30:00 Close Bipasa Sen Comprehensive Family support: Resilience and quality of life Sunila Khandelwal Mindbody Medicine at Midlife Anju Soni Sails of Spirituality to Navigate Midlife Interactive Discussion Symposium Bone Conundrums 3 Credits 1:30:00 Close Tobie De Villiers Early Menopause: A window of opportunity for the prevention of bone lossPeter Ebeling Let’s Start at The Beginning: A bone friendly lifestyleDavid Scott Sarcopenia: Can we make progress without a universally accepted definition? Debate MHT initiation should be limited to women < age 60 or within 10 years of FMP 2 Credits 1:00:00 Close Susan Davis OpposedMary Ann Lumsden Affirmative Symposium Progestogens 2 Credits 1:00:00 Close Alfred Mueck Progestogens and their Effects on other Steroid ReceptorsAntonio Cano Progestogens: Which one, when, how much, how long? Sponsored Symposium Non-Ablative ErYAG Laser for GSM: 10 years' experience 2 Credits 1:00:00 Close Marco Gambacciani Vaginal Erbium Laser for GSM: OverviewZdenko Vizintin Intraurethral Approach for Laser Treatment of Urinary Symptoms of GSM and SUI Symposium by CAMS Society Fertility in late reproductive age 2 Credits 1:00:00 Close Tommaso Simoncini Fertility and contraception during the late reproductive ageAngelica Lindén Hirschberg Autoimmunity and FertilityEleni Armeni Fertility Treatment and Cardiovascular Disease: An overview Sponsored Lunch Symposium A Mind & Body Perspective on Menopause and the Role of Duavive 3 Credits 1:30:00 Close Steven R. Goldstein Menopause and Breasts: Why is there still a concern about MHT and breast cancer?Sonia Davison The Menopausal Mind: How do hormone fluctuations affect the brain and cause cognitive symptoms of menopause? Duavive FAQ: How does Duavive fit into clinical practice? Symposium Obesity Management 3 Credits 1:30:00 Close Panagiotis Anagnostis It’s Frustrating: Menopause related changes in body composition, weight gain & diabetesJohn Dixon Weight Management: What works and for whom?Priya Sumithran GLP1 Analogues for Obesity in Menopausal Women Symposium Perimenopause 3 Credits 1:30:00 Close Richard Anderson Perimenopause: Making the diagnosisPaula Briggs Perimenopausal ContraceptionSteven R. Goldstein Management of Bleeding During the Perimenopause and Menopause Sponsored Symposium Genitourinary Syndrome of Menopause: Treatment of Vulvo Vaginal Atrophy with intravaginal DHEA (Prasterone) 3 Credits 1:30:00 Close Terri Foran Welcome and Introduction Terri Foran Genitourinary Syndrome of Menopause: Underdiagnosed and undertreated, an Australian perspective Tommaso Simoncini Intravaginal DHEA (Prasterone): MOA endocrinology (androgenic effect)Elizabeth Farrell Treatment of Vulvo Vaginal Atrophy with Intravaginal DHEA (Prasterone) in Post-Menopausal Women Having Moderate to Severe Symptoms: Clinical data Panel Discussion: Case scenarios Panel Discussion: Q&A from audienceTerri Foran Closing Remarks Symposium by CAMS Society Beyond Vasomotor Symtoms 3 Credits 1:30:00 Close Saima Zubair Healthy Aging and Its Impact on LongevitySumbul Sohail Gender Matters in the Manifestation of Heart Disease: Statistics from PakistanSaima Hanan Body Image and Its Correlation with Depression During Menopausal Transition Symposium by CAMS Society SYMPTOMATIC, METABOLIC AND ONCOLOGICAL CONNOTATIONS OF MENOPAUSE 3 Credits 1:30:00 Close Andres Calle-Miñaca Demographic Aspects of Menopause in Ecuador José Mendoza Andramuño Obesity and Metabolic Syndrome in Peri- and Post-Menopause Hernán Neira Maldonado Estrogenic Contraception in Perimenopause Wellington Aguirre Solís Effect of Altitude on Vasomotor Symptoms Plenary Lecture Laser for GSM: What We Know and What We Need to Know 1 Credit 30:00 Close Jason Abbott Laser for GSM: What we know and what we need to know Meet the Expert MHT in complex patients: Assessing absolute risk and benefit 2 Credits 1:00:00 Close Sylvia Rosevear MHT in Complex Patients: Assessing absolute risk and benefit Meet the Expert Managing menopause after cancer 2 Credits 1:00:00 Close Mary Ann Lumsden Managing Menopause after Cancer Meet the Expert Androgens other than testosterone 2 Credits 1:00:00 Close Andrea Genazzani Androgens other than Testosterone Plenary Lecture Menopause, Women and the Workplace 1 Credit 30:00 Close Karen Walker Bone Menopause, Women and the Workplace Plenary Lecture Bringing Sex Back into the Relationship 1 Credit 30:00 Close Rossella Nappi Bringing Sex Back Into the Relationship Symposium Menopause and Lifestyle 3 Credits 1:30:00 Close Robin Daly Lifestyle Management of Menopause: What’s really effective?Martha Hickey An Empowerment Model for Managing MenopauseKerri Melehan Sleep Disturbances in the Menopause Transition Oral Communication General Menopause 2 Credits 1:00:00 Close Caroline Gurvich Cognition during menopauseEu-Leong Yong Menopausal Arthralgia: Prevalence and Risk Factors from the Integrated Women’s Health Program (IWHP) longitudinal cohortCamille Cronin Effect of Physical Activity on Wellbeing among Working Menopausal Women in EnglandMasakazu Terauchi Severe tiredness in middle-aged women is associated with insomnia and depression Symposium by CAMS Society PANAMENIAN SOCIETY OF OBSTETRICS AND GINECOLOGY (SPOG) 2 Credits 1:00:00 Close Ibell Sarmiento Menopause and Musculoskeletal HealthCarmen Troya Premature Ovarian Insufficiency: Innovative approach to understanding and managementKonstantinos Tserotas Cognitives Changes in Perimenopause and Possible Relationship with Insulin and Estrogen Closing Ceremony Closing Remarks 2 Credits 15:00 Close Nick Panay Rossella Nappi Symposium Menopause in Southeast Asia 2 Credits 1:00:00 Close Fidel Ganis Siregar Menopause in IndonesiaUnnop Jaisamrarn Menopause in ThailandMaria Jesusa Banal-Silao Menopause in PhilippinesBeng Kwang Ng Menopause in Malaysia Oral Communication Bone Loss and Osteoporosis 2 Credits 1:00:00 Close Takumi Kurabayashi Importance of changes in BMI from adolescence to middle age as risk factors for osteoporosis: The Japan Nurses’ Health StudyOracha Chucherd The Association of Sarcopenic Obesity with Osteoporosis in Postmenopausal WomenJoelle Tan MRI-derived Muscle Fat Infiltration reduces strength and physical performance in midlife Asian womenSutrisno Sutrisno Phaleria Macrocarpa Flavonoids May Increase Trabeculae, Cortex Thickness Ratio and Osteocytes Count in Femoral Bone of Menopausal Mice ModelSangeeta Mehrotra The silent burden: prevalence and knowledge of osteoporosis in perimenopausal & postmenopausal women in Indian setting, a community based survey. Symposium by CAMS Society The British Menopause Society Management of the Menopause Certificate 2 Credits 1:00:00 Close Haitham Hamoda The new BMS Management of the Menopause CertificateKate Ellis Meeting the Demand for Gold-Standard Menopause Education in the 21st Century Oral Communication Cognitive Function and sleep 2 Credits 1:00:00 Close Farhana Sultana Associations between blood sex steroids, cognitive decline and incident dementia in community-dwelling older Australian womenNguyen Xuan Phuong Le The proportion of Plant-based food in daily diet during midlife and cognitive health in later life in Australian women – Data from the Women’s Healthy Ageing Project (WHAP)Andrea Murphy Sleeping pill discontinuation experiences in post-menopausal women: analysis from the Stopping Insomnia Medications in Older Adults (SIMOA) surveyAndrea Murphy Stopping long-term BZRAs with direct-to-patient mailed interventions: an analysis of effectiveness and safety data for females from the YAWNS NB studyFarhana Sultana Is cognitive decline in women from the age 70 years associated with declining blood testosterone concentrations Oral Communication Epidemiology and clinical research 3 Credits 1:30:00 Close Chen Liang Is there a link between infertility, miscarriage, stillbirth, and age at natural menopause? Results from pooled analyses of nine cohort studiesWei Wang Establishment and prospective of OvaRePred, a non-invasive AI tool for ovarian reserve assessment and prediction in reproductive womenHsin-Fang Chung Menstrual disorders in young adulthood and risk of early menopause: results from the Australian Longitudinal Study on Women's HealthTamami Odai Oxidative balance score is associated vasomotor symptoms and social health in middle-aged and elderly Japanese women: a cross-sectional studySantiago Palacios The Effect of Estetrol (E4) on Patient-Reported Outcome Measures in Postmenopausal Women – Results from a Phase 3 TrialTommaso Simoncini Estetrol (E4), a Promising New Treatment for Menopausal Vasomotor Symptoms: Beneficial Lipid and Carbohydrate Metabolism in a Phase 3 Randomized, Double-blind, Placebo-Controlled TrialJennifer Hirst Inequalities in hormone replacement therapy prescribing in UK primary care – An analysis of electronic health records of 2 million women 2013-2023Elena Ermakova National Survey on MHT among Russian Gynecologists and Patients Oral Communication Sleep Cognition Wellbeing 2 Credits 1:00:00 Close Svetlana Dubrovina Change the paradigm about menopausal hormone therapy during perimenopause: violet study resultsLinda Dear Māori experiences of Menopause - Insights from the Menodoctor Survey NZXiuying Chen A survey of menopausal symptoms and the knowledge level relevant to menopause among 5200 women over 40 years old in Shanghai, ChinaTaylor Roebotham A prospective, descriptive study of women 65 years and over who use systemic Menopause Hormone TherapySusan Goldstein A new evidence-based online interactive decision tool to support menopause management: the MQ6 Interactive Treatment Algorithm Symposium Late Breaking News 2 Credits 1:00:00 Close Sonia Davison Sonia’s SnippetsSeng Bin Ang What's That on Your Wrist? - All about wearables Symposium Osteoporosis: When and How 3 Credits 1:30:00 Close Eugene McCloskey Diagnosis and Intervention ThresholdsBronwyn Stuckey Pharmacological Treatment for Fracture Prevention: What is the role of MHT?Santiago Palacios Anabolic Treatment Fracture Prevention: New perspectives Oral Communication Pelvic Organ Prolapse 2 Credits 1:00:00 Close Dmitry Subbotin Comparison of a Novel Hammock-Sacrocolpopexy Method with Traditional Laparoscopic Sacrocolpopexy in Treating Cystocele in WomenParamdeep Singh Dynamic Magnetic Resonance Imaging (MRI) for assessment of pelvic organ prolapse in asymptomatic postmenopausal women without clinically evident pelvic organ descentTomas Fait Treatments of vulvovaginal laxity by electroporation therapyBelisa Brunow Ventura Biavatti Minimally invasive sacrohysteropexy vs vaginal hysterectomy for uterovaginal prolapse: a systematic review and meta-analysisTolu Adedipe A tale of 2 domiciles: Menopause experiences in the Sub-Saharan African woman in LMIC versus HIC settings Symposium by CAMS Society Enhancing menopause awareness, management and training among clinicians 2 Credits 1:00:00 Close Maria Jesusa Banal-Silao Clinical Profile of Menopausal Women and Attitudes Towards Hormone Therapy in the PhilippinesMaria Antonia Habana Improving Care: Supporting menopause clinics across the countryEileen Manalo Coming Full Circle with Menopause Hormone Therapy Oral Communication Hormone Therapy and Breast Cancer 2 Credits 1:00:00 Close Lorhayne Kerley Capuchinho Scalioni Galvão Omitting Axillary Dissection In Breast Cancer With Sentinel-Node Metastases: A Systematic Review And Meta-Analysis Of Randomised Controlled TrialsJohn Eden Why does hormonal contraception and menopausal hormonal treatment have such a small effect on breast cancer risk? A clinical perspective.Yinghuang Wang The effects of menopausal hormone therapy on breast density in perimenopausal and postmenopausal women: A systematic review and network meta-analysisSujjanna A.L. Manuel HRT Experience in women after cancer treatment at Secondary care. Oral Communication Menopause and Brain & Mood and Mental Disorders 2 Credits 1:00:00 Close Peter Werner Heger THE SPECIAL EXTRACT ERr 731® ALLEVIATED MOOD DISORDERS IN SYMPTOMATIC PERIMENOPAUSAL WOMENMing Jun Kuck Stress, depression, and anxiety: psychological complaints across menopausal stagesClaudio Soares Psychedelics and Mental Health during Menopause: from Underground to Mainstream, Challenges and Clinical OpportunitiesGhazala Sadiq A review of cognitive performance during menopausal transition among working women in Islamabad PakistanXiaolin Xu Depression during perimenopause and progression of chronic conditions and multimorbidity: results from a Chinese prospective cohort Oral Communication Vulvovaginal Atrophy/Genitourinary Syndrome 2 2 Credits 1:00:00 Close Anita Brown-Major Creating an anatomically correct model of the clitoris and vulva - CliterateTamas Major Vaginal Erbium:YAG laser treatment for stress urinary incontinence in peri- and postmenopausal womenAgnieszka Nalewczyńska The safety and efficacy of a vaginal pixel-CO2 laser procedure for the treatment of stress urinary incontinence (SUI).Suji Choi Evaluating the Efficacy of Thread Embedding Acupuncture on Overactive Bladder in Postmenopausal Women: A Randomized Controlled TrialTing Guo Intratumor fungi probing reveals commensal aspergillus clavatophorus in ovarian cancer Oral Communication Oncology and Endometrium 2 Credits 1:00:00 Close Silvia Martella Use of hormonal replacement therapy (HRT) in women with oncological menopause referred to a III-level oncological centerJames Simon Evaluation of the risk of endometrial cancer in menopausal women using vaginal oestrogenMonal Garg A Tale of Two Tumours: Comparison of Oncological Outcomes in Pure and Mixed Uterine Serous CarcinomasMonal Garg The Impact of Surgical Approach on Surgical Outcomes in Early-Stage Endometrial Cancer: A Comparative Analysis of Robotic-Assisted vs. Open SurgeryXi Yuan AMH Level Is Decreased in the Presence of Endometriosis in the Asian Population, Regardless of Severity and Treatment Status Oral Communication Metabolic Disorders 3 Credits 1:30:00 Close Nilufar Bakoeva Premature ovarian insufficiency following COVID-19: mechanisms involving kisspeptin and brain-derived neurotrophic factorJeremy Knott Post-menopausal virilisation due to ovarian hyperthecosis with improved glycaemic control post-resection: case reportAnju Soni Evaluating the severity of menopausal symptoms among postmenopausal women screened for metabolic syndromeAnditha Namira Rezky Sitompul The Effect Of Soy Isoflavone Administration On Homeostatic Model Assesment Insuline Resistance (HOMA-Ir) In Indonesian Post-Menopause WomenRajlaxmi Mundhra The relationship between Serum vitamin D levels and metabolic syndrome among postmenopausal women from Uttarakhand, India- a cross sectional studyLawrence Marapo Metabolic Syndrome in Peri and Post Menopausal Women at Tertiary Hospital in South AfricaDonya Derakshani A Systematic Review of the Influence of Various Hormone Therapies on Metabolic Dysfunction-Associated Steatotic Liver DiseaseWen Shen Hypoestrogenic states and the impacts of testosterone therapy among transmasculine and gender diverse individuals Oral Communication Quality of Life and complex menopause 2 Credits 1:00:00 Close M. Ernesto Azguevara Ganis Siregar Exploring Therapeutic Avenues: An Experimental Study Investigating the Effects of Soy Isoflavone and Estradiol Valerate on HbA1c, Lipid Profile, Urogenital Complaints, Vaginal Maturity Index, and Sexual Function in Menopausal Women — A Comparative Analysis using MENQOL-Quality of Life Assessment.Nabia Tariq Quality of life for working women in Midlife and BeyondSuchanant Chavaengkiat Testosterone effects on Quality of Life and Sexual Function Among Hormone-Naive Transmasculine in ThailandMona Polavarapu Study of Sexuality and Quality of Life in Peri and Postmenopausal Solid Organ Transplant RecipientsNgoy Kabuya Graci The Problems of Aging Women Living with Hiv Under ARV Treatment in the DRCTolu Adedipe Menopause in the Sub-Saharan African woman: Prevalence, experience, knowledge, health-seeking behaviour and treatment. Oral Communication Menopause New treatments 2 3 Credits 1:30:00 Close Qi Yu Ultra-low-dose estradiol and dydrogesterone: a phase III study for vasomotor symptoms in ChinaJohn Stevenson Major Adverse Cardiovascular Event Risk in Menopausal Women Treated With Oral Estradiol/Micronized Progesterone Versus Conjugated Estrogens/Medroxyprogesterone: US Claims Data AnalysisJohn Stevenson Comparison of ultra-low-dose oral versus transdermal hormone replacement therapy (HRT) on coagulation activation and metabolic risk factors for cardiovascular disease (CVD).Ladan Yeganeh Knowledge gaps and barriers to cardiovascular disease prevention in midlife women in AustraliaRossella Nappi Correlation between fezolinetant treatment of vasomotor symptoms associated with menopause and impact on work productivity: data from two phase 3 studiesChristine Kemp What trade-offs are Australian women willing to make when choosing between potential treatments for moderate-to-severe vasomotor symptoms associated with menopause?Farid Abdul Hadi Targeted Literature Review of Concepts Related to Women’s Experiences of Vasomotor Symptoms Associated with MenopauseGraciella Angelica Lukas Does Daily Magnesium Intake Have Impact on Lowering Blood Pressure Among Postmenopausal Women with Hypertension Residing in a Nursing Home? Oral Communication Epidemiology 3 Credits 1:30:00 Close Hugo Gutiérrez-Crespo Representations of menopause in Peruvian womenRakib Islam Exploring Heterogeneity Between Menopausal Status and Depression: Three National Surveys with a Causal Forest ApproachSarah Hillman Menopause GAP: exploring inequalities in menopause care in GenerAl Practice in England using qualitative methodologySantiago Palacios Development of a Menopausal Treatment Tool to help clinicians evaluate the benefit/risk of Menopause Hormonal Therapy in symptomatic menopausal women: Results from an international study.Shahina Zahoor A survey of Pakistani women to determine there Attitudes and knowledge of the Menopause .Amanda Clark Assessment of a Menopause Curriculum for Practicing Primary Care CliniciansPeter Chedraui Mid-aged women’s health: an integral program in Ecuador Oral Communication SOUTHERN STARS: BEST ABSTRACTS BY YOUNG INVESTIGATORS 3 Credits 1:30:00 Close Fiona Li The effects of repeat fractional CO2 laser for postmenopausal vaginal symptoms following unblinding from a double-blind RCTMaryam Jahangirifar The Prevalence and Severity of Vasomotor and Sexual Symptoms Among Refugee Women in AustraliaMícheál Ó Breasail Impact of HIV on radial bone density, geometry, and strength in midlife Zimbabwean WomenGemma Sharp Developing an educational resource for people experiencing eating disorders during the menopausal transition: A qualitative co-design studyHyemin Park COVID-19 Vaccination and the Risk of Post-menopausal Bleeding: a population-based self-controlled case series studyYuejiao Wang MicroRNA-181a Negatively Regulates E2-Combined NET-promoted Cell Viability and Migration through Promoting Autophagy in PGRMC1-overexpressing Breast Cancer Cells Oral Communication Vulvovaginal Atrophy/Genitourinary Syndrome 1 3 Credits 1:30:00 Close Kitti Chattrakulchai Urinary Microbiomes in Postmenopausal Women With or without Urinary Symptoms of GSM; A Cross-sectional StudyAsna Beg Ashraf The prevalence and characteristics of genitourinary syndrome of menopause: a multi-centre, Indian Midlife Registry based studyWoraluk Somboonporn Vaginal estriol for lower urinary tract symptoms in menopausal womenCéline Bouchard Deep Beneficial Effects of Vaginal Prasterone (Intrarosa®) on the Vaginal Histology of Women with Genitourinary Syndrome of Menopause (GSM) Treated or not with Aromatase Inhibitors (AI).Rosalind Foster Genitourinary syndrome of menopause in Chinese-speaking sex workers attending an urban Australian sexual health clinicMadhulika Agarwal Non-hormonal soy isoflavone vaginal gel an effective treatment option in relieving symptoms of vulvovaginal atrophy in post-menopausal women.Mariam Iqbal Use of Erbium laser in vaginal atrophy after menopauseIngrid Pinas Low-dose vaginal estrogen for sexual pain after breast cancer treatment – case report and literature highlights Oral Communication Hormones, Metabolism and Obesty 3 Credits 1:30:00 Close maninder ahuja Relation of menopause to metabolic syndrome -in Indian womenFederica Barbagallo Relationship between serum follicle-stimulating hormone levels and metabolism in postmenopausal womenTrinidia Lubis The Effect Of Soy Isoflavone Administration On Hba1c Levels In Menopause Women : A Randomised Controlled Trial StudyEnkhee Sodnomdorj The association between the 25(oh)d concentration and menopausal symptomatology in mongolian womenDebra Bourke Estetrol/drospirenone oral contraceptive impact on lipid parameters in 40-50-year-oldsJyothika Desai Anthropometric measures of Indian women at midlife and beyond and their association with non-communicable diseasesAditi Verma Risk factors associated with obesity among midlife women: Insights from a Cross-sectional surveyYoujuan Pei Study on the Changes of Carotid Artery Intima-Media Thickness and Its Influencing Factors in PCOS Patients Oral Communication Vulvovaginal atrophy and Laser 2 Credits 1:00:00 Close Marco Gambacciani The effects of hyaluronic acid administration in postmenopausal women treated with the erbium SMOOTH® laser for genitourinary syndrome of menopause.Tünde Bartha Effectiveness of vaginal Erbium:YAG laser in the treatment of genitourinary syndrome of the menopause in patients with failed local treatmentSuchanant Chavaengkiat Improvement of sexual function after vaginal Erbium-YAG laser therapy among postmenopausal women with genitourinary syndrome of menopauseGemma Sharp A qualitative analysis of women’s experiences with vaginal CO2 laser treatmentsAgnieszka Nalewczyńska Evaluation of the effect of submucosal injections of Platelet-Rich Plasma with hyaluronic acid (PRP-HA) in women with vaginal dryness. Oral Communication Premature Ovarian Insufficiency 2 Credits 1:00:00 Close Tamás Deli POI in Turner syndrome: correlation of karyotype, age at diagnosis and former growth hormone therapy with phenotype and comorbiditiesSunila Khandelwal Women with POI and IVF Outcome Variables with Donor Oocyte in Recipient Age Specific GroupsSvetlana Yureneva INFLUENCE OF GSTP1 GENETIC VARIATION ON RESPONSE TO HORMONE REPLACEMENT THERAPY IN WOMEN WITH PREMATURE OVARIAN INSUFFICIENCYHyun Joo Lee A national cohort study of hormone therapy timing and chronic disease in primary ovarian insufficiencyAttila Jakab Significant change in the prevalence of etiological factors in POI over two decades – a single center experience Oral Communication Menopause at Workplace 2 Credits 1:00:00 Close Sasha Taylor Menopause and work performance: a systematic reviewMargaret Noyes Essex Women at work: Exploring the menopause workplace experience in the United States, Australia, and New Zealand – data from an employee research initiativeErin Morton Menopause: not yet in the Australian workplaceCamille Cronin Menopause in the workplace – an organisation-based case studyNancy Li The impact of podcast media on chinese women's perceptions and attitudes towards menopause in the digital era Oral Communication Menopause New Treatments 1 3 Credits 1:30:00 Close Robin Andrews Menopausal Symptom Patterns & Severities According to Medical ProfilesRaymond Hang Wun Li Climacteric symptomatology profile of women in the perimenopause and postmenopause: a territory-wide observational study in Hong KongHannah Graetz A pilot of physiotherapy and supervised exercise for women presenting to a tertiary medical menopause clinic with severe and complex symptoms of menopausePauline Maki Vasomotor symptoms and the impact of sleep disturbance associated with menopause among postmenopausal women in EuropeMarla Shapiro C.M. Patient-Reported Outcomes in Phase 3b DAYLIGHT: Fezolinetant for Menopause-Associated Vasomotor SymptomsAntonio Cano Efficacy of fezolinetant for improving patient-reported sleep outcomes: results from two phase 3 studies for vasomotor symptoms associated with menopauseAngelica Lindén Hirschberg Early Response with Fezolinetant for Menopause-Associated Vasomotor Symptoms in Phase 3b DAYLIGHTClaudio Soares Exploring Sleep Disturbances Across Age and Sex with Wearable Smartwatches How it works Purchase credits Buy the credits needed to access On Demand content. Select your Sessions Choose the sessions you want to watch from the available options Watch the videos The system will deduct the corresponding number of credits for that session Lectures will be available to watch for 12 months starting November 11th, 2024. Start creating your account! FAQ What is IMS 2024 On Demand? IMS 2024 On Demand is a digital service that allows you to access the content from the 19th IMS Congress held in Melbourne from October 19 to 22, 2024. It enables you to watch sessions on demand, offering flexibility for those who are unable to attend in person. How do I access IMS 2024 On Demand? You can access IMS 2024 On Demand by purchasing credits through our online platform. Once you have purchased credits, you can use them to watch the sessions of your choice. How do credits work? Each credit corresponds to 30 minutes of video content. For example, if you wish to watch a plenary lecture that lasts 30 minutes, you will need to use 1 credit. What types of sessions are available in IMS 2024 On Demand? You can access a wide range of session types, including plenary lectures, symposiums and oral presentations. The content covers various topics related to menopause and women’s health. How many credits do I need to watch different types of sessions? The number of credits required depends on the length of the session. For instance, a 30-minute session requires 1 credit, a 60-minute session requires 2 credits, and so on. A detailed credit guide is available on our website. Can I purchase additional credits if I run out? Yes, you can purchase additional credits at any time if you need more to watch additional sessions. Is there a time limit on when I can use my credits? Your credits can be used until November 20th, 2025. Can I share my credits with others? No, credits are non-transferable and linked to your personal account. Each user must purchase their own credits to access the content. Will the sessions be available in different languages? The primary language of the sessions is English. However, all sessions offer translations in Chinese, Portuguese, Russian and Spanish. Who can I contact if I have issues accessing the content? If you encounter any problems or have questions about IMS 2024 On Demand, please contact our support team at help@btcongress.com. We’re here to help! I purchased registration for the on-site congress in Melbourne. Do I need to buy credits to watch the On Demand sessions? No, your on-site registration already includes access to the on-demand version of the congress at no additional cost. You will be able to watch the sessions on demand after the congress concludes. I’m registered for the on-site congress but can no longer attend. Can I request a refund and switch to the On Demand option? If you are unable to attend the on-site congress, you may request a refund according to our cancellation policy. Please note that your on-site registration includes access to the On Demand version of the congress. Therefore, switching to the on-demand option alone will not be considered valid grounds for a refund after the deadline of July 15, 2024. If I already have an account but did not complete the registration, can I choose the On Demand version and finalize my registration? Yes, you can select the On Demand version and complete your registration by logging into your personal account.